Literature DB >> 16782483

Mild cognitive impairment.

Peter Whitehouse, Henry Brodaty.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16782483     DOI： 10.1016/S0140-6736(06)68880-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  The future of incidental findings: should they be viewed as benefits?

Authors:  Lisa S Parker
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

Review 2.  Huperzine A for mild cognitive impairment.

Authors:  Jirong Yue; Bi Rong Dong; Xiufang Lin; Ming Yang; Hong Mei Wu; Taixiang Wu
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

3.  Non-pharmacological intervention for memory decline.

Authors:  Maria Cotelli; Rosa Manenti; Orazio Zanetti; Carlo Miniussi
Journal:  Front Hum Neurosci       Date:  2012-03-09       Impact factor: 3.169

Review 4.  Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.

Authors:  Roberto Raschetti; Emiliano Albanese; Nicola Vanacore; Marina Maggini
Journal:  PLoS Med       Date:  2007-11-27       Impact factor: 11.069

5.  Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study.

Authors:  Takuya Yagi; Michio Kanekiyo; Junichi Ito; Ryoko Ihara; Kazushi Suzuki; Atsushi Iwata; Takeshi Iwatsubo; Ken Aoshima
Journal:  Alzheimers Dement (N Y)       Date:  2019-08-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.